• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Novo Nordisk A/S Common Stock (NY:NVO)

    48.45 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Feb 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 120,239
    Open 48.45
    Bid (Size) 47.90 (100)
    Ask (Size) 47.92 (500)
    Prev. Close 48.45
    Today's Range 48.45 - 48.45
    52wk Range 43.08 - 93.80
    Shares Outstanding N/A
    Dividend Yield 2.41%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Is Pfizer Stock the Only Big Pharma Name I'd Buy and Hold Through Any Market Crash? ↗
    New products are already generating growth. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street ↗
    These biotech companies have catalysts ahead. 
    Via The Motley Fool

    Performance

    YTD
    -7.5%
    -7.5%
    1 Month
    -20.2%
    -20.2%
    3 Month
    +1.8%
    +1.8%
    6 Month
    -12.6%
    -12.6%
    1 Year
    -41.9%
    -41.9%

    More News

    Read More
    News headline image
    Warning: This Skyrocketing Stock Has a Hidden Risk ↗
    Via The Motley Fool
    Topics Intellectual Property
    Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report ↗
    Via Stocktwits
    HIMS Stock Plunges 8 Straight Days: Is The GLP-1 Fallout Already Priced In? ↗
    Via Stocktwits
    News headline image
    Overlooked and Undervalued: Why Novo Nordisk Stock Deserves Attention ↗
    Via The Motley Fool
    News headline image
    Hims & Hers HUGE Acquisition News! ↗
    Via The Motley Fool
    News headline image
    Forget Ozempic: This Obesity‑Drug Giant Is Grabbing the Biggest Slice of the GLP‑1 Gold Rush ↗
    Via The Motley Fool
    News headline image
    The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    NVO Stock Generates Retail Buzz After European Commission Approves 7.2 MG Once-Weekly Dose Of Wegovy Injection ↗
    Via Stocktwits
    Topics Lawsuit
    News headline image
    2026 Could Be a Big Year for Viking Therapeutics. Time to Buy? ↗
    Via The Motley Fool
    News headline image
    Novo Nordisk's New Diabetes Drug Outshines Ozempic: Is The Stock a Buy? ↗
    Via The Motley Fool
    News headline image
    Got $500? 2 Pharma Stocks to Buy and Hold Forever. ↗
    Via The Motley Fool
    News headline image
    Novo Nordisk To Meet Wegovy Pill Demand In US Before Expanding To Avoid Supply Shortage, Says CEO Doustdar ↗
    Via Stocktwits
    Topics Lawsuit
    News headline image
    Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? ↗
    Via Stocktwits
    News headline image
    Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know. ↗
    Via The Motley Fool
    News headline image
    Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs ↗
    Via Benzinga
    News headline image
    Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    The Greenland Gambit: Inside the Transatlantic Tariff Shock and the Future of Arctic Sovereignty
    Via MarketMinute
    Topics Bonds Economy Government
    News headline image
    Disney Has Its Next CEO ↗
    Via The Motley Fool
    News headline image
    Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip. ↗
    Via The Motley Fool
    News headline image
    Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore ↗
    Via The Motley Fool
    News headline image
    Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Novo Nordisk A/S Common Stock publicly traded?
    Yes, Novo Nordisk A/S Common Stock is publicly traded.
    What exchange does Novo Nordisk A/S Common Stock trade on?
    Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Novo Nordisk A/S Common Stock?
    The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
    What is the current price of Novo Nordisk A/S Common Stock?
    The current price of Novo Nordisk A/S Common Stock is 48.45
    When was Novo Nordisk A/S Common Stock last traded?
    The last trade of Novo Nordisk A/S Common Stock was at 02/19/26 07:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.